Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

April 3, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Urinary Retention
Interventions
DRUG

Tamsulosin

Tamsulosin 0.4 mg one time daily after a meal for seven days prior to surgery. Post-surgery, an ultrasound of the bladder will be completed approximately six hours after surgery to assess the bladder. If the bladder ultrasound shows more than 400 cc of urine in the bladder, or if the study subject passes urine on his own and there is more than 100cc or less than 400 cc of urine left in the bladder, he will be encouraged to try to pass urine. Study subject will be monitored for two additional hours. If a study subject is unable to pass urine at this time or the bladder has 400 cc or more of urine left in it, he will have an intermittent catheter (in and out) to drain urine. If the bladder has greater than 500 cc (which is approximately 16 and two-thirds ounces) per catheterization for more than 24 hours, and the study subject cannot pass urine, an indwelling catheter may be considered.

Trial Locations (4)

08724

RECRUITING

Ocean University Medical Center, Brick

08050

RECRUITING

South Ocean University Medical Center, Manahawkin

07753

RECRUITING

Jersey Shore University Medical Center, Neptune City

07701

RECRUITING

Riverview Medical Center, Red Bank

All Listed Sponsors
lead

Hackensack Meridian Health

OTHER